Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET: Ticagrelor vs Aspirin post-CABG
NCT02053909Phase 4Completed
- Sponsor
- Boca Raton Regional Hospital
- Start
- Sep 2014
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ticagrelor in saphenous vein graft disease (SVGD), sponsored by Boca Raton Regional Hospital. Started Sep 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
saphenous vein graft disease (SVGD)
Beyond the preview
Go deeper on NCT02053909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053909.